Aurobindo Pharma gets USFDA nod for its expectorant tablets

The company has received final approval from the United States Food and Drug Administration (USFDA) to manufacture its generic Guaifenesin extended-release tablets in the strengths of 600 mg and 1,200 mg.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news